{
    "@context": "https://schema.org",
    "@type": "Article",
    "headline": "OIG Guidance on Fraud and Abuse Implications of Free Covid-19 Antibody Testing by Laboratories",
    "url": "https://www.lexblog.com/2020/09/01/oig-guidance-on-fraud-and-abuse-implications-of-free-covid-19-antibody-testing-by-laboratories/",
    "identifier": {
        "@type": "PropertyValue",
        "name": "LexBlog Library record",
        "value": "LEX-WK-FBZREF54",
        "url": "https://www.lexblog.com/lib/FBZREF54/"
    },
    "datePublished": "2020-09-01T16:33:59-04:00",
    "dateModified": "2024-05-01T14:13:49-04:00",
    "author": {
        "@type": "Person",
        "name": "Cori Turner, Erica M. Ash, Tracey Toll"
    },
    "sourceOrganization": {
        "@type": "Organization",
        "name": "Husch Blackwell LLP"
    },
    "organizationScope": "at-publication",
    "isPartOf": "Healthcare Law Insights",
    "about": "Health Care and Life Sciences",
    "sourceUrl": "https://www.healthcarelawinsights.com/?p=4844",
    "sourceStability": "may-move"
}